Showing results (111-120 of 668) with videos related to
Sort By:
Pageof 67
Advances in Pharmacology (San Diego, Calif.)|January 21, 2015
The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autismHanns MöhlerAdvances in Pharmacology (San Diego, Calif.)|January 21, 2015
Regulation of GABAARs by phosphorylationYasuko Nakamura, Laura M Darnieder, Tarek Z Deeb, et al.Advances in Pharmacology (San Diego, Calif.)|January 21, 2015
Inhibitory neurosteroids and the GABAA receptorSandra Seljeset, Duncan Laverty, Trevor G SmartAdvances in Pharmacology (San Diego, Calif.)|January 21, 2015
GABAA receptor partial agonists and antagonists: structure, binding mode, and pharmacologyJacob Krall, Thomas Balle, Niels Krogsgaard-Larsen, et al.Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Functional Selectivity at Cannabinoid ReceptorsRichard Priestley, Michelle Glass, David KendallAdvances in Pharmacology (San Diego, Calif.)|August 23, 2017
Cannabinoids in the Cardiovascular SystemWing S V Ho, Melanie E M KellyAdvances in Pharmacology (San Diego, Calif.)|August 23, 2017
Cannabis Pharmacology: The Usual Suspects and a Few Promising LeadsEthan B Russo, Jahan MarcuAdvances in Pharmacology (San Diego, Calif.)|June 8, 2021
Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic applicationNorbert E Kaminski, Barbara L F KaplanAdvances in Pharmacology (San Diego, Calif.)|June 8, 2021
Vaccines as therapies for food allergiesJeffrey J Landers, Jessica J O'KonekAdvances in Pharmacology (San Diego, Calif.)|June 8, 2021
The role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilitiesRobert A Freeborn, Cheryl E RockwellPageof 67